Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model.

dc.contributor.authorCostelli, Paolacat
dc.contributor.authorCarbó Carbó, Neuscat
dc.contributor.authorTessitore, Lucianacat
dc.contributor.authorBagby, Gregory J.cat
dc.contributor.authorLópez-Soriano, Francisco J.cat
dc.contributor.authorArgilés Huguet, Josep Ma.cat
dc.contributor.authorBaccino, Francesco M.cat
dc.date.accessioned2009-05-14T10:14:17Z
dc.date.available2009-05-14T10:14:17Z
dc.date.issued1993cat
dc.description.abstractRats bearing the Yoshida AH-130 ascites hepatoma showed enhanced fractional rates of protein degradation in gastrocnemius muscle, heart, and liver, while fractional synthesis rates were similar to those in non-tumor bearing rats. This hypercatabolic pattern was associated with marked perturbations of the hormonal homeostasis and presence of tumor necrosis factor in the circulation. The daily administration of a goat anti-murine TNF IgG to tumor-bearing rats decreased protein degradation rates in skeletal muscle, heart, and liver as compared with tumor-bearing rats receiving a nonimmune goat IgG. The anti-TNF treatment was also effective in attenuating early perturbations in insulin and corticosterone homeostasis. Although these results suggest that tumor necrosis factor plays a significant role in mediating the changes in protein turnover and hormone levels elicited by tumor growth, the inability of such treatment to prevent a reduction in body weight implies that other mediators or tumor-related events were also involved.eng
dc.format.extent7 p.cat
dc.format.mimetypeapplication/pdfeng
dc.identifier.idgrec79740cat
dc.identifier.issn0021-9738cat
dc.identifier.pmid8254032
dc.identifier.urihttps://hdl.handle.net/2445/8263
dc.language.isoengeng
dc.publisherAmerican Society for Clinical Investigationcat
dc.relation.isformatofReproducció del document publicat a http://dx.doi.org/doi:10.1172/JCI116897cat
dc.relation.ispartofJournal of Clinical Investigation, 1993, vol. 92, núm. 6, p. 2783-2789.cat
dc.rights(c) The American Society for Clinical Investigation, 1993
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Bioquímica i Biomedicina Molecular)
dc.subject.classificationTumorscat
dc.subject.classificationNecrosicat
dc.subject.classificationMúsculscat
dc.subject.otherTumor necrosis factoreng
dc.subject.otherSkeletal muscleeng
dc.subject.otherProtein turnovereng
dc.titleTumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model.eng
dc.typeinfo:eu-repo/semantics/articleeng
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
79740.pdf
Mida:
1.25 MB
Format:
Adobe Portable Document Format